Analysis

The final week of June is shaping up as a make-or-break moment for Green Bridge Metals, with a triple set...

The Danish pharmaceutical heavyweight arrived at the American Diabetes Association congress in New Orleans armed with a double dose of...

It was always going to be a strategic trade-off: sell uranium into a softening spot market or hold tight and...

The divergence between Ocugen's scientific trajectory and its stock price has rarely been starker. The biotech's shares closed at €1.05...

Amazon is pulling out all the stops this summer, yet the stock is struggling to find its footing. The e-commerce...

Small municipalities like Kitzingen and Rauschenberg are already struggling to staff daycare centres, even as a new study projects the...

The Danish drugmaker entered the week with a promising oral medication and emerged facing a cybersecurity crisis and a clinical...

Extreme volatility has become the defining characteristic of POET Technologies, with shares lurching between double-digit gains and deep sell-offs as...

The gap between Strategy’s operational reality and its stock price has never been wider. Shares of the Bitcoin treasury company...

The market does not always reward operational progress. Uranium Energy’s latest quarterly report offered genuine milestones — first production at...